Using a WT8 subclone in which CCL2 was overexpressed and a 786‐O subclone in which CCL2 expression was knocked down, we found that CCL2 overexpression enhanced and CCL2 knockdown suppressed tumor growth, angiogenesis, and macrophage infiltration in vivo. The gene discussed is CCL2; the disease is neoplasm.